Also trades as: LUN.CO (CPH) · $vol 10M · HLUN-B.CO (CPH) · $vol 4M · HLUN-A.CO (CPH) · $vol 1M · HLUYY (OTC) · $vol 0M · HLUBF (OTC) · $vol 0M

$6.76

+0.00 (+0.00%)

OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 50 · $5.4B mcap · 305M float · 0.0002% daily turnover · Short 81% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

Income Trends

Revenue

$24.3B +10.4% ▲

5Y CAGR: +6.6%

Gross Profit

$19.3B +8.8% ▲

5Y CAGR: +7.4%

Operating Income

$6.3B +93.5% ▲

5Y CAGR: +26.0%

Net Income

$3.2B +1.3% ▲

5Y CAGR: +15.0%

EPS (Diluted)

$3.21 +1.3% ▲

5Y CAGR: -16.6%

EBITDA

$7.3B +28.4% ▲

5Y CAGR: +8.5%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$16.3B	$18.2B	$19.9B	$22.0B	$24.3B
YoY Growth	-7.7%	+11.9%	+9.1%	+10.5%	+10.4%
Cost of Revenue	$3.6B	$4.0B	$4.5B	$4.2B	$5.0B
Gross Profit	$12.7B	$14.3B	$15.4B	$17.8B	$19.3B
Gross Margin	77.6%	78.3%	77.5%	80.8%	79.6%
R&D Expenses	$3.8B	$3.8B	$3.5B	$4.5B	$4.7B
SG&A Expenses	$6.8B	$7.7B	$8.8B	$9.6B	$8.8B
Operating Expenses	$10.6B	$11.4B	$12.2B	$14.5B	$13.0B
Operating Income	$2.0B	$2.9B	$3.2B	$3.3B	$6.3B
Operating Margin	12.3%	15.6%	16.0%	14.9%	26.0%
Interest Expense	$153M	$103M	$54M	$113M	$540M
Income Before Tax	$1.6B	$2.5B	$3.0B	$3.7B	$4.5B
Tax Expense	$263M	$558M	$703M	$576M	$1.3B
Net Income	$1.3B	$1.9B	$2.3B	$3.1B	$3.2B
Net Margin	8.1%	10.5%	11.5%	14.3%	13.1%
EPS (Diluted)	$1.33	$1.93	$2.31	$3.17	$3.21
EBITDA	$3.4B	$4.4B	$5.1B	$5.7B	$7.3B
Shares Outstanding	993M	993M	992M	992M	992M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$5.7B	$5.5B	$6.2B	$6.0B	$6.3B	$6.1B	$7.0B	$6.5B
Cost of Revenue	$1.1B	$1.1B	$1.1B	$1.1B	$846M	$1.9B	$1.4B	$1.4B
Gross Profit	$4.6B	$4.5B	$5.2B	$4.9B	$5.4B	$3.8B	$5.6B	$5.1B
Gross Margin	80.9%	80.7%	82.6%	81.9%	86.5%	62.7%	80.0%	79.0%
R&D Expenses	$1.5B	$1.1B	$1.2B	$1.1B	$1.2B	$1.3B	$1.3B	$1.4B
SG&A Expenses	$2.3B	$2.8B	$2.2B	$2.3B	$2.3B	$2.4B	$2.1B	$2.2B
Operating Expenses	$3.8B	$4.3B	$3.5B	$3.4B	$3.8B	$2.4B	$3.3B	$3.6B
Operating Income	$811M	$177M	$1.7B	$1.6B	$1.6B	$375M	$2.4B	$1.5B
Operating Margin	14.2%	3.2%	27.2%	26.1%	26.0%	6.2%	33.6%	23.7%
Interest Expense	$79M	$0	$221M	$333M	$219M	$15M	$29M	$27M
Income Before Tax	$732M	$680M	$1.5B	$1.2B	$1.4B	$360M	$2.1B	$1.5B
Tax Expense	-$45M	$90M	$325M	$272M	$311M	$387M	$468M	$322M
Net Income	$777M	$590M	$1.2B	$966M	$1.1B	-$27M	$1.7B	$1.1B
Net Margin	13.6%	10.6%	18.5%	16.0%	17.5%	-0.4%	23.6%	17.6%
EPS (Diluted)	$0.78	$0.60	$1.16	$0.97	$1.11	$-0.03	$1.67	$1.18
EBITDA	$811M	$739M	$1.7B	$1.6B	$1.6B	$101M	$2.8B	$2.0B
Shares Outstanding	992M	992M	992M	996M	992M	992M	992M	992M

HLBBF OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet